Tetrandrine in the Treatment of Rheumatoid Arthritis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to assess the efficacy and safety of tetrandrine, compared with placebo in 12 week or 24 week in RA patients with inadequate response to methotrexate.
Epistemonikos ID: f629688b95401a6bfc727c007e32f697f52a301e
First added on: May 10, 2024